Clinical application of circulating tumor cells.

Area of Science:

• Oncology
• Biomarker Discovery
• Molecular Diagnostics

Background:

• Circulating tumor cells (CTCs) are shed from primary tumors into the bloodstream.
• CTC analysis is emerging as a powerful tool in understanding cancer progression and treatment.
• Epithelial cancers represent a significant global health burden, necessitating advanced diagnostic and prognostic tools.

Purpose of the Study:

• To provide a comprehensive overview of current CTC analysis techniques and their clinical significance in epithelial cancers.
• To explore advancements in CTC detection, clinical applications, and future challenges.
• To highlight the potential of CTCs as non-invasive biomarkers for personalized medicine and treatment monitoring.

Main Methods:

• Narrative review of existing literature on CTC analysis.
• Examination of research findings on CTC detection methods and clinical applications.
• Analysis of the role of CTCs in tumor biology, treatment response, and prognostic evaluation.

Main Results:

• CTC analysis provides valuable insights into tumor biology, treatment response, minimal residual disease, and prognosis.
• CTCs show potential as non-invasive biomarkers for personalized medicine and monitoring treatment efficacy.
• Current challenges include standardization, validation, and integration into routine clinical practice.

Conclusions:

• CTC analysis is a rapidly evolving field with significant potential to impact clinical practice in epithelial cancers.
• Further research and standardization are needed to overcome existing challenges.
• CTC analysis holds promise for improving patient outcomes and guiding therapeutic decision-making.